Ex vivo drug sensitivity screening in multiple myeloma identifies drug combinations that act synergistically.

Mol Oncol · 2022 · PMC8936517 · PMID 35148457

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a trend toward significanceno p-value reported

Altogether, patients classified as responders ( n = 9) displayed a trend toward significance of increased ex vivo sensitivity (median DSS of 51.8), compared to patients achieving a poor response ( n = 4) (median DSS of 23.4) [minimal response (MR) = 1, stable disease (SD) = 1, progressive disease (PD) = 2] (Fig. 7F ).

also in 3,729 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.